Search bioRxiv⌕ Search

Biology subjects

Lindberg, S. K.

Publications and source records attributed to Lindberg, S. K..

3 recordsLinked to original sources

A Salmonella enterica serovar Typhimurium Genome-wide CRISPRi Screen Reveals a Role for Type 1 Fimbriae in Evasion of Antibody-Mediated Agglutination

The O5-specific monoclonal IgA antibody, Sal4, mediates the conversion of Salmonella enterica serovar Typhimurium (STm) from virulent, free-swimming cells to non-motile, multicellular aggregates in solution ("flocs") as well as biofilm-like associations at the air-liquid interface (ALI). We hypothesize that the rapid transition from an invasive to a non-invasive state reflects an adaptation of STm to Sal4 IgA exposure. In this report, we performed a genome-wide CRISPRi screen to identify STm genes that influence multicellular aggregate formation in response to Sal4 IgA treatment. From a customized library of >36,000 spacers, [~]1% (373) were enriched at ALI after two consecutive rounds of Sal4 IgA treatment. The enriched spacers mapped to a diversity of targets, including genes involved in O-antigen modification, cyclic-di-GMP metabolism, outer membrane biosynthesis/signaling, and invasion/virulence, with the most frequently targeted gene being fimW, which encodes a negative regulator of Type 1 Fimbriae (T1F) expression. Generation of a STm {Delta}fimW strain confirmed that the loss of FimW results in a hyperfimbriated phenotype and evasion of Sal4 IgA-mediated agglutination in solution. Closer examination of the fimW mutant revealed its propensity to form biofilms at the ALI specifically in response to Sal4 exposure, suggesting that T1F "primes" STm to transition from a planktonic to a sessile state possibly by facilitating bacterial attachment to abiotic surfaces. These findings shed light on the mechanism by which protective secretory IgA antibodies influence STm virulence in the intestinal environment.

microbiology↗

mRNA delivery of dimeric human IgA protects mucosal tissues from bacterial infection

Monoclonal antibody (mAb) therapy is a promising infectious disease intervention strategy but is limited to IgG1 isotypes that have restricted access to mucosal sites. IgA is well-established as the predominant antibody isotype in mucosal secretions but is clinically underutilized. To enable development of IgA-based mAbs, we exploited mRNA platform technology and demonstrated expression of functional, antigen-specific IgA (IgAmRNA) that can limit bacterial invasion in the intestine and prevent colonization in the lung. Moreover, in vivo IgAmRNA had enhanced serum half-life and a greater degree of sialylation than a recombinantly produced IgA. The results underscore the potential of mRNA-based platforms to deliver protective human mAbs to mucosal surfaces and open new avenues to combat infectious diseases in the face of pervasive antibiotic resistance. One Sentence SummarymRNA-encoded human monoclonal IgA traffics to mucosal tissues and provides protection against bacterial challenge

immunology↗

IQGAP1 connects phosphoinositide signaling to cytoskeletal reorganization

IQGAP1 is a multi-domain protein that acts as a scaffold for multiple signaling pathways. IQGAP1 generates the lipid messenger PI(3,4,5)P3 by scaffolding the phosphoinositide kinases PIPKIs and PI3K. The dynamics of this scaffolding protein complex in intact, living cells are unknown. Here, we delineate the role of IQGAP1 in PI(3,4,5)P3-mediated signaling in live cells under basal and stimulated conditions using fluorescence lifetime imaging microscopy. We demonstrate that IQGAP1 interacts strongly with PIPKI{gamma} at intracellular entities and on the plasma membrane, and scaffolds PI3K and PIPKI{gamma} in response to physiological changes. Additionally, we show that IQGAP1 scaffolds phosphoinositides with PI3K, PIPKI{gamma} and EGFR, and forms clusters upon cell stimulation with epidermal growth factor. Importantly, we show that IQGAP1 connects PI(3,4,5)P3-mediated signaling and cytoskeletal signaling pathways by binding PIPKI{gamma} in proximity of the cytoskeletal proteins talin and Cdc42. Our results support a model in which IQGAP1 mediates crosstalk between phosphoinositide signaling and the cytoskeleton to promote directed cell movement.

biophysics↗